|Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer|
S Shu, CY Lin, HH He, RM Witwicki, DP Tabassum, JM Roberts, ...
Nature 529 (7586), 413-417, 2016
|CDK7-dependent transcriptional addiction in triple-negative breast cancer|
Y Wang, T Zhang, N Kwiatkowski, BJ Abraham, TI Lee, S Xie, H Yuzugullu, ...
Cell 163 (1), 174-186, 2015
|Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study|
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet, 2020
|Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors|
VA Adalsteinsson, G Ha, SS Freeman, AD Choudhury, DG Stover, ...
Nature communications 8 (1), 1-13, 2017
|A delicate balance: TGF‐β and the tumor microenvironment|
DG Stover, B Bierie, HL Moses
Journal of cellular biochemistry 101 (4), 851-861, 2007
|Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer|
B Bierie, CH Chung, JS Parker, DG Stover, N Cheng, A Chytil, M Aakre, ...
The Journal of clinical investigation 119 (6), 1571-1582, 2009
|Transforming growth factor–β regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment|
B Bierie, DG Stover, TW Abel, A Chytil, AE Gorska, M Aakre, E Forrester, ...
Cancer research 68 (6), 1809-1819, 2008
|Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells|
B Bierie, SE Pierce, C Kroeger, DG Stover, DR Pattabiraman, P Thiru, ...
Proceedings of the National Academy of Sciences 114 (12), E2337-E2346, 2017
|CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer|
SF Johnson, C Cruz, AK Greifenberg, S Dust, DG Stover, D Chi, ...
Cell reports 17 (9), 2367-2381, 2016
|Treatment of juvenile xanthogranuloma|
DG Stover, S Alapati, O Regueira, C Turner, JA Whitlock
Pediatric blood & cancer 51 (1), 130-133, 2008
|Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies|
YZ Jiang, D Ma, C Suo, J Shi, M Xue, X Hu, Y Xiao, KD Yu, YR Liu, Y Yu, ...
Cancer cell 35 (3), 428-440. e5, 2019
|Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases|
J Ni, SH Ramkissoon, S Xie, S Goel, DG Stover, H Guo, V Luu, E Marco, ...
Nature medicine 22 (7), 723-726, 2016
|Association of cell-free DNA tumor fraction and somatic copy number alterations with survival in metastatic triple-negative breast cancer|
DG Stover, HA Parsons, G Ha, SS Freeman, WT Barry, H Guo, ...
Journal of Clinical Oncology 36 (6), 543, 2018
|Cancer cells co-opt the neuronal redox-sensing channel TRPA1 to promote oxidative-stress tolerance|
N Takahashi, HY Chen, IS Harris, DG Stover, LM Selfors, RT Bronson, ...
Cancer cell 33 (6), 985-1003. e7, 2018
|TGF‐β promotes cell death and suppresses lactation during the second stage of mammary involution|
B Bierie, AE Gorska, DG Stover, HL Moses
Journal of cellular physiology 219 (1), 57-68, 2009
|Flash mob research: a single-day, multicenter, resident-directed study of respiratory rate|
MW Semler, DG Stover, AP Copland, G Hong, MJ Johnson, MS Kriss, ...
Chest 143 (6), 1740-1744, 2013
|Intracardiac thrombus: diagnosis, complications and management|
UO Egolum, DG Stover, D Lenihan, JB Damp, R Anthony, AM Wasserman
The American journal of the medical sciences 345 (5), 391-395, 2013
|Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing|
AM Cushman-Vokoun, DG Stover, Z Zhao, EA Koehler, JD Berlin, ...
Clinical Colorectal Cancer 12 (3), 168-178, 2013
|Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer|
DG Stover, CRG Del Alcazar, J Brock, H Guo, B Overmoyer, J Balko, Q Xu, ...
NPJ Breast Cancer 4 (1), 1-9, 2018
|Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments|
DG Stover, N Wagle
Current oncology reports 17 (4), 15, 2015